Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
Add more filters










Publication year range
1.
Toxins (Basel) ; 13(6)2021 05 21.
Article in English | MEDLINE | ID: mdl-34064255

ABSTRACT

The present study was designed to determine the efficacy of a novel multicomponent mycotoxin detoxifying agent (MMDA) containing modified zeolite (Clinoptilolite), Bacillus subtilis, B. licheniformis, Saccharomyces cerevisiae cell walls and silymarin against the deleterious effects of Aflatoxin B1 (AFB1) and Ochratoxin A (OTA) in broiler chicks. A total of 160 one-day-old Ross 308® broiler chicks were randomly allocated in four treatment groups, with four replicates, according to the following experimental design for 42 days. Group A received a basal diet; Group B received a basal diet contaminated with AFB1 and OTA at 0.1 mg/kg and 1 mg/kg, respectively; Group C received a basal diet contaminated with AFB1 and OTA and MMDA at 1 g/kg feed, and Group D received a basal diet contaminated with AFB1 and OTA and MMDA at 3 g/kg feed. Results showed that ingested mycotoxins led to significant (p ≤ 0.05) reduction in body weight and feed conversion from 25 days of age, induced histopathological changes, increased the pH of the intestinal content, and altered the biochemical profile of birds with significantly (p ≤ 0.05) increased aspartate aminotransferase (AST) values (p ≤ 0.05). On the other hand, the supplementation of MMDA significantly (p ≤ 0.05) improved the feed conversion ratio (FCR) during the second part of the study, diminished biochemical alterations, reduced pH in jejunal and ileal content, and E. coli counts in the caeca of birds (p ≤ 0.05). It may be concluded that the dietary supplementation of the MMDA partially ameliorated the adverse effects of AFB1 and OTA in broilers and could be an efficient tool in a mycotoxin control program.


Subject(s)
Aflatoxin B1/poisoning , Mycotoxicosis/drug therapy , Ochratoxins/poisoning , Silymarin/administration & dosage , Zeolites/administration & dosage , Animal Feed , Animals , Bacillus licheniformis , Bacillus subtilis , Chickens , Mycotoxicosis/metabolism , Mycotoxicosis/pathology , Random Allocation , Saccharomyces cerevisiae
2.
J Vet Med Sci ; 81(8): 1162-1172, 2019 Aug 24.
Article in English | MEDLINE | ID: mdl-31270307

ABSTRACT

The metabolism of aflatoxin B1 (AFB1) generates reactive oxygen species (ROS) that destroys hepatocytes. Meanwhile, astaxanthin (AX) is known to have stronger antioxidative activity than other carotenoids. This study aimed to investigate hepatoprotective role of AX from AFB1-induced toxicity in rat by histopathological study and immunohistochemistry of Cu/Zn-SOD (SOD1) which acts as the first enzyme in antioxidative reaction against cell injury from ROS. Twenty Wistar rats were randomly divided into 4 groups. The control and AFB1 groups were gavaged by water for 7 days followed by a single DMSO and 1 mg/kg AFB1, respectively. The AXL+ AFB1 and AXH+ AFB1 groups were given of 5 mg/kg and 100 mg/kg AX for 7 days before 1 mg/kg AFB1 administration. The result showed significantly elevated liver weight per 100 g body weight in AFB1 group. The histopathological finding revealed vacuolar degeneration, necrosis, megalocytosis and binucleation of hepatocytes with bile duct hyperplasia in AFB1 group. The severities of pathological changes were sequentially reduced in AXL+AFB1 and AXH+AFB1 groups. Most rats in AXH+AFB1 group owned hypertrophic hepatocytes and atypical proliferation of cholangiocytes which are adaptive responses to severe hepatocyte damage. The SOD1 expression was also significantly higher in AXH+AFB1 group than solely treated AFB1 and AXL+AFB1 groups. In conclusion, AX alleviated AFB1-induced liver damage in rat by stimulating SOD1 expression and transdifferentiation of cholangiocytes in dose dependent manner.


Subject(s)
Aflatoxin B1/toxicity , Antioxidants/pharmacology , Liver/drug effects , Poisons/toxicity , Superoxide Dismutase/metabolism , Animals , Antioxidants/therapeutic use , Drug Interactions , Liver/enzymology , Liver/pathology , Liver Diseases/drug therapy , Liver Diseases/pathology , Mycotoxicosis/drug therapy , Mycotoxicosis/pathology , Oxidative Stress/drug effects , Rats , Rats, Wistar , Reactive Oxygen Species/metabolism , Xanthophylls/pharmacology , Xanthophylls/therapeutic use
3.
Toxicon ; 167: 1-5, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31173793

ABSTRACT

Fumonisin B1 (FB1), the most toxic member of fumonisins, is one of the most common mycotoxins contaminating feed and food. It has been shown to produce pleiotropic toxicities in animals including neurotoxicity, hepatotoxicity and nephrotoxicity, and with highly potential impact on human health. Proposed mechanisms include disruption of sphingolipid metabolism, induction of oxidative stress, activation of endoplasmic reticulum (ER) stress and MAPKs, modulation of autophagy and alteration of DNA methylation. These mechanistic findings provide the theoretical basis for effectively managing FB1-induced adverse health effects. In this review, we will summarize the present understanding of the molecular basis underlying FB1-mediated toxicities, discuss the feasibility of developing mechanism-based approach to prevent FB1-induced toxicities, and suggest the issues that need to be addressed in the future in the field of FB1 toxicity-related studies.


Subject(s)
Fumonisins/toxicity , Mycotoxicosis/drug therapy , Mycotoxins/toxicity , Animals , Autophagy/drug effects , Fumonisins/chemistry , Humans , Liver/drug effects , Mycotoxins/chemistry , Oxidative Stress/drug effects , Sphingolipids/metabolism
4.
Rev. med. interna Guatem ; 20(1): [1-8], ene.-mar. 2016. tab
Article in Spanish | LILACS | ID: biblio-986291

ABSTRACT

La intoxicación por hongos, especialmente con fines alimenticios, es un importante problema terapéutico. El hongo Chlorophyllum molybdites, es uno de los principales agentes causantes de intoxicación en países Latinoameri-canos, debido a su similitud con el hongo Agaricus comestible. Se presentan dos casos de intoxicación por Chlorophyllum molybdites los cuales fueron ingeridos y posteriormente desarrollaron manifes-taciones clínicas. Se presenta con su revisión bibliográfica centrada en las diferentes opciones terapéuticas...(AU)


Subject(s)
Humans , Male , Female , Child , Middle Aged , Mycotoxicosis/drug therapy , Mushroom Poisoning/prevention & control , Foodborne Diseases/etiology , Agaricales/classification , Guatemala
5.
PLoS One ; 9(11): e112357, 2014.
Article in English | MEDLINE | ID: mdl-25405987

ABSTRACT

The purpose of this study was to investigate the hypothesis that dietary supplementation with glutamic acid has beneficial effects on growth performance, antioxidant system, intestinal morphology, serum amino acid profile and the gene expression of intestinal amino acid transporters in growing swine fed mold-contaminated feed. Fifteen pigs (Landrace×Large White) with a mean body weight (BW) of 55 kg were randomly divided into control group (basal feed), mycotoxin group (contaminated feed) and glutamate group (2% glutamate+contaminated feed). Compared with control group, mold-contaminated feed decreased average daily gain (ADG) and increased feed conversion rate (FCR). Meanwhile, fed mold-contaminated feed impaired anti-oxidative system and intestinal morphology, as well as modified the serum amino acid profile in growing pigs. However, supplementation with glutamate exhibited potential positive effects on growth performance of pigs fed mold-contaminated feed, ameliorated the imbalance antioxidant system and abnormalities of intestinal structure caused by mycotoxins. In addition, dietary glutamate supplementation to some extent restored changed serum amino acid profile caused by mold-contaminated feed. In conclusion, glutamic acid may be act as a nutritional regulating factor to ameliorate the adverse effects induced by mycotoxins.


Subject(s)
Amino Acid Transport Systems/metabolism , Glutamic Acid/pharmacology , Intestines/drug effects , Mycotoxicosis/veterinary , Mycotoxins/toxicity , Amino Acid Transport Systems/genetics , Amino Acids/blood , Animals , Body Weight , Case-Control Studies , Dietary Supplements , Glutamic Acid/administration & dosage , Intestinal Mucosa/metabolism , Intestines/pathology , Mycotoxicosis/drug therapy , Swine
6.
Toxicol Ind Health ; 29(2): 121-5, 2013 Mar.
Article in English | MEDLINE | ID: mdl-22080034

ABSTRACT

Aflatoxicosis is a cause of economic losses in broiler production. In this study, the effect of one commercial nanocompound, Nanocid (Nano Nasb Pars Co., Iran) was evaluated in reduction of aflatoxin effects on the growth and performance indices in broiler chickens suffering from experimental aflatoxicosis. For this, a total of 300 one-day-old broiler chicks (Ross strain) were randomly divided into 4 groups with 3 replicates of 15 chicks in each separated pen during the 28-day experiment. Treatment groups including group A: chickens fed basal diet, group B: chickens fed 3 ppm productive aflatoxin in basal diet, group C: chickens fed basal diet plus 2500 ppm Nanocid, and group D: chickens fed 3 ppm productive aflatoxin and 2500 ppm Nanocid, in basal diet. Data on body weight, body weight gain (BWG), feed intake, and feed conversion ratio (FCR) were recorded at weekly intervals. Also cumulative data were assessed. Results showed, although supplement of Nanocid to conventional diet had no effect on performance but addition of Nanocid to diet containing 3 ppm aflatoxin increased significantly the cumulative BWG, cumulative feed consumption and decreased FCR in the last 2 weeks of experimental period. The improvement in these performance indices by supplement of Nanocid to diet containing aflatoxin showed the ability of Nanocid to diminish the inhibitory effects of aflatoxin.


Subject(s)
Aflatoxins/toxicity , Chickens/growth & development , Metal Nanoparticles/administration & dosage , Mycotoxicosis/drug therapy , Poisons/toxicity , Poultry Diseases/drug therapy , Silver Compounds/pharmacology , Animals , Diet , Disease Models, Animal , Eating/drug effects , Food Contamination , Mycotoxicosis/etiology , Mycotoxicosis/physiopathology , Poultry Diseases/chemically induced , Poultry Diseases/physiopathology , Weight Gain/drug effects
7.
Toxicon ; 56(1): 8-18, 2010 Aug 01.
Article in English | MEDLINE | ID: mdl-20230848

ABSTRACT

Exposure to fumonisins (FB) is known to have toxic and carcinogenic effects in different animal species, and to express toxicity in cells via the induction of oxidative stress. The aim of the current study was to evaluate the protective effects of the ethanol extract of Aquilegia vulgaris L. against the oxidative stress and the genotoxicity using micronucleus assay and random amplified polymorphism DNA (RAPD-PCR) in FB-treated rats. Sixty mature female Sprague-Dawley were divided into six treatment groups and treated for 4 weeks as follow: the control group, the group fed FB-contaminated diet (200 mg/kg diet), the groups treated orally with the extract (5 and 10 mg/kg bw) and the groups fed FB-contaminated diet and treated with the extract at the two doses. The results showed that treatment with FB alone disturbed lipid profile in serum, increases Sa/So ratio, induces micronucleated polychromatic erythrocytes (Mn-PCEs) in bone marrow, increases DNA and RNA in liver accompanied with significant changes in histological picture The extract alone at the two tested doses did not induce any significant changes in the biochemical or histological picture. The combined treatment showed significant improvements in all biochemical, cytogenetic parameters tested and histological pictures in the liver tissues. Moreover, this improvement was more pronounced in the group received the high dose of the extract. It could be concluded that the ethanol extract of A. vulgaris induced its protective effect via the increase in the antioxidant capacity, inhibition of lipid peroxidation and scavenging of free radicals.


Subject(s)
Antioxidants/therapeutic use , Aquilegia/chemistry , Fumonisins/toxicity , Mycotoxicosis/drug therapy , Oxidative Stress/drug effects , Phytotherapy , Plant Extracts/therapeutic use , Animals , Antioxidants/administration & dosage , Antioxidants/metabolism , Bone Marrow Cells/drug effects , Bone Marrow Cells/pathology , Dose-Response Relationship, Drug , Female , Foodborne Diseases/drug therapy , Foodborne Diseases/metabolism , Lipid Peroxidation/drug effects , Lipids/blood , Liver/drug effects , Liver/metabolism , Liver/pathology , Medicine, Traditional , Micronuclei, Chromosome-Defective/chemically induced , Micronuclei, Chromosome-Defective/drug effects , Mutagens/toxicity , Mycotoxicosis/metabolism , Nucleic Acids/metabolism , Plant Extracts/administration & dosage , Plant Leaves/chemistry , Plant Stems/chemistry , Rats , Rats, Sprague-Dawley , Sphingosine/analogs & derivatives , Sphingosine/metabolism
8.
Trop Anim Health Prod ; 40(8): 649-56, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18975130

ABSTRACT

The efficacy of locally produced bentonite was evaluated with respect to ameliorating the adverse effects of aflatoxins (AF) in piglets fed AF contaminated diets. Forty eight piglets were randomly assigned to one of four treatments: 1) 0 g of bentonite and 0 microg AF/kg feed (control); 2) 4 g of bentonite plus 200 microg AF/kg feed (AF + Bento 4); 3) 5 g of bentonite plus 200 microg AF/kg feed (AF + Bento 5) and 4) 0 g of bentonite plus 200 microg AF/kg feed (AFA). Piglets in the AFA treatment had lower overall average daily weight gain (ADG), feed conversion efficiency, albumin (ALB) and total protein (TP) compared to the control diet, while mean serum leukocyte and enzyme activities (glutamic-oxalacetic transaminase (GOT), glutamic-pyruvic transaminase (GPT), gamma glutamyltransferase (GGT), alkaline phosphate (ALP) and lactic dehydrogenase (LDH)) were significant increased. The inclusion of bentonite at 0.4% or 0.5% in the AF contaminated diet restored the lower performance, feed efficiency and abnormal blood profiles of the piglets given AF and no differences between 0.4 and 0.5% inclusion of bentonite. The findings in the present study provide critically needed confirmation that bentonite has the ability to reduce the adverse effects of AF.


Subject(s)
Aflatoxins/poisoning , Antidotes/administration & dosage , Bentonite/administration & dosage , Mycotoxicosis/drug therapy , Mycotoxicosis/veterinary , Swine Diseases/drug therapy , Administration, Oral , Animals , Body Weight/drug effects , Dose-Response Relationship, Drug , Female , Food Contamination , Male , Mycotoxicosis/enzymology , Swine , Swine Diseases/blood , Swine Diseases/enzymology
9.
Br Poult Sci ; 49(5): 632-42, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18836911

ABSTRACT

1. Toxic effects of two concentrations (0.5 and 1 mg/kg) of ochratoxin A (OTA) and attenuating effects of a toxin deactivator (Mycofix Plus(MTV INSIDE)) containing the yeast Trichosporon mycotoxinivorans on the performance (feed conversion ratio; body weight gain), serum enzymes (lactate dehydrogenase, gamma-glutamyltranspeptidase and aspartate aminotransferase) and clinico-pathomorphology of internal organs were studied in 270 one-day-old broiler chicks divided into 9 groups over a 42-d period. 2. Feed conversion ratios (FCR) in groups fed toxin deactivator were improved compared with groups receiving OTA only. An increase in the relative weight of kidney and liver was observed in groups fed 0.5 and 1 mg/kg OTA on day 42 of the experiment as compared with the control group. In contrast, relative weights of bursa of Fabricius and spleen were not significantly affected in experimental groups exposed to OTA as compared to control groups determined on days 28 and 42 of age. 3. Serum enzymes (LDH, GGT and AST) values in OTA treated groups determined on days 28 and 42 were higher than those of the control group. 4. Histopathological examination of kidney on day 42 revealed degenerative changes in the epithelial cells of the proximal convoluted tubules and massive necrosis of the proximal tubular epithelial cells. These changes were less marked in birds receiving 0.5 mg/kg OTA than in those receiving 1 mg/kg. In general, histological changes in kidneys, liver, bursa and spleen were less pronounced in birds receiving OTA and toxin deactivator concomitantly. 5. Dietary OTA at 0.5 and 1 mg/kg adversely affects FCR, increases the serum liver enzymes and induces pronounced pathomorphological and histological changes in internal organs of broiler chicks. Co-administration of OTA with deactivator attenuated the harmful effects.


Subject(s)
Iodophors/pharmacology , Mycotoxicosis/drug therapy , Ochratoxins/toxicity , Poultry Diseases/drug therapy , Animal Feed , Animals , Bursa of Fabricius/drug effects , Bursa of Fabricius/pathology , Chickens , Diet/veterinary , Dose-Response Relationship, Drug , Iodophors/administration & dosage , Kidney/drug effects , Kidney/pathology , Liver/drug effects , Liver/pathology , Ochratoxins/administration & dosage , Organ Size , Spleen/drug effects , Spleen/pathology , Weight Gain/drug effects
10.
Mikrobiol Z ; 70(1): 52-8, 2008.
Article in Ukrainian | MEDLINE | ID: mdl-18416155

ABSTRACT

When Road-Island breed chickens were given fodder which included toxin in concentration of 16 mg/kg or T-2 toxin in concentration of 10 Mg/kg, that resulted in the decrease of the live weight, increase in the relative weight of the liver, kidneys, pancreas and heart, as well as the decrease of concentration of Bacillus genus bacteria in the caecum and rectum content compared with the control group chickens. No distinctions were observed in activity of alanine aminotransferase and concentration of total protein in the blood plasm. The drinking of probiotic preparation BPS-44 when feeding with forage contaminated by HT-2 or T-2 toxin resulted in the increase of the live weight, normalization of relative weights of viscera, increase in concentration of Bacillus genus bacteria in the intestine compared with chickens which received only mycotoxins.


Subject(s)
Bacillus subtilis/growth & development , Chickens , Mycotoxicosis/drug therapy , Poultry Diseases/drug therapy , Probiotics/therapeutic use , Animal Feed , Animals , Body Weight/drug effects , Chickens/growth & development , Food Contamination , Intestine, Large/drug effects , Intestine, Large/microbiology , Mycotoxicosis/blood , Mycotoxicosis/veterinary , Organ Size/drug effects , Poultry Diseases/blood , Probiotics/administration & dosage , T-2 Toxin/toxicity
11.
Mycol Res ; 110(Pt 9): 1003-10, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16908123

ABSTRACT

Recent aggressive attacks on innocent citizens have resulted in governments increasing security. However, there is a good case for prevention rather than reaction. Bioweapons, mycotoxins, fungal biocontrol agents (FBCA), and even pharmaceuticals contain, or are, toxins and need to be considered in the context of the new paradigm. Is it desirable to discuss such issues? None of the fungi are (a) as toxic as botulinum toxin from Clostridium botulinum, and (b) as dangerous as nuclear weapons. One toxin may be defined as a pharmaceutical and vice versa simply by a small change in concentration or a moiety. Mycotoxins are defined as naturally occurring toxic compounds obtained from fungi. They are the biggest chronic health risk when incorporated into the diet. The current list of fungal toxins as biochemical weapons is small, although awareness is growing of the threats they may pose. T-2 toxin is perhaps the biggest concern. A clear distinction is required between the biological (fungus) and chemical (toxin) aspects of the issue. There is an obvious requirement to be able to trace these fungi and compounds in the environment and to know when concentrations are abnormal. Many FBCA, produce toxins. This paper indicates how to treat mycotoxicosis and decontaminate mycotoxins. There is considerable confusion and inconsistency surrounding this topic which requires assessment in an impartial and scientific manner.


Subject(s)
Biological Warfare , Bioterrorism , Fungi/metabolism , Mycotoxicosis/prevention & control , Mycotoxins , Fungi/genetics , Humans , Mycotoxicosis/drug therapy , Mycotoxins/biosynthesis , Mycotoxins/chemistry , Mycotoxins/toxicity
12.
East Afr Med J ; 82(6): 320-4, 2005 Jun.
Article in English | MEDLINE | ID: mdl-16175785

ABSTRACT

The objective of this presentation is to document the salient clinical findings in a case of aflatoxicosis and to review the literature on the same so as to increase the index of suspicion, enhance early diagnosis and improve management. The case was a 17-year-old schoolboy presenting with vomiting, features of infection and gastrointestinal tract symptoms. Examination revealed a very ill looking pale patient with abdominal distension, tenderness and rectal bleeding and easy bruisability. Investigations showed abnormal liver function tests, pancytopenia and elevated serum levels of aflatoxins. Management consisted of supportive care including antibiotics and antifungal therapy, transfusion of red blood cells and fresh frozen plasma. His recovery was uneventful. The literature on human aflatoxicosis shows that the presentation may be acute, subacute and chronic. The degree of emanating clinical events also conforms to status of the aflatoxicosis. Overall, the features are protean and may masquerade many other forms of toxaemias. In conclusion, the diagnosis of aflatoxicosis takes cognisance of geographical location, past events, staple diet and clinical features to exclude other infections. Also required are high index of suspicion and importantly serum levels of aflatoxin. Treatment strategies involved use of antimicrobials and supporting the damaged multi-organs.


Subject(s)
Aflatoxins/poisoning , Mycotoxicosis/diagnosis , Acute Disease , Adolescent , Anti-Bacterial Agents/therapeutic use , Antifungal Agents/therapeutic use , Blood Transfusion , Diagnosis, Differential , Early Diagnosis , Foodborne Diseases , Humans , Liver Function Tests , Male , Mycotoxicosis/drug therapy , Mycotoxicosis/therapy
13.
Acta Vet Hung ; 53(3): 319-24, 2005.
Article in English | MEDLINE | ID: mdl-16156127

ABSTRACT

This study was designed to evaluate the effect of L-carnitine supplementation on the plasma malondialdehyde (MDA) and whole blood reduced glutathione (GSH) concentrations in experimentally-induced chronic aflatoxicosis in quails. For this purpose, a total of 80 quails up to 8 weeks old were divided into four equal groups. Group I served as control, Group II was given L-carnitine at the dose of 200 mg/litre in the drinking water for 60 days, Group III was given 60 microg total aflatoxin/kg diet for 60 days, and Group IV was given both 60 microg total aflatoxin/kg diet and 200 mg L-carnitine/litre in the drinking water for 60 days. Aflatoxin treatment caused a significant increase in plasma MDA and a significant decrease in blood GSH concentrations. On the other hand, there was a significant decrease in plasma MDA and a significant increase in whole blood GSH in the L-carnitine-supplemented group. The present study demonstrated that L-carnitine brought about the inhibition of lipid peroxidation by enhancing antioxidant capacity in quails with chronic aflatoxicosis.


Subject(s)
Aflatoxins/antagonists & inhibitors , Carnitine/therapeutic use , Coturnix/metabolism , Lipid Peroxidation/drug effects , Mycotoxicosis/veterinary , Poultry Diseases/drug therapy , Aflatoxins/toxicity , Animal Feed , Animals , Dietary Supplements , Mycotoxicosis/drug therapy , Mycotoxicosis/metabolism , Poultry Diseases/chemically induced , Poultry Diseases/metabolism
14.
Br Poult Sci ; 46(3): 394-400, 2005 Jun.
Article in English | MEDLINE | ID: mdl-16050196

ABSTRACT

We evaluated the efficacy of yeast glucomannan (Mycosorb), incorporated into the diet at 0.5 and 1 g/kg, in reducing the detrimental effects of 2 mg aflatoxin/kg diet on growing broiler chicks from 1 to 21 d of age. A total of 240 male broiler chicks (Ross-308) was divided into 6 treatment groups [Control, Aflatoxin (AF), Yeast glucomannan (YG; 0.5 g/kg), AF plus YG (0.5 g/kg), YG (1 g/kg), and AF plus YG (1 g/kg)]. Ten chicks from each of the 6 groups were slaughtered and pathological examinations were performed on the liver, bursa of Fabricius, thymus, spleen and kidney. The aflatoxin treatment caused moderate to severe hydropic/fatty degeneration in the hepatocytes of the liver and the tubular epithelium of the kidneys, and follicular depletion in the bursa of Fabricius, thymus and spleen. Yeast glucomannan added to the aflatoxin-containing diet at 0.5 and 1 g/kg diminished the severity of pathological changes, slightly and moderately, respectively. The number of affected organs was also reduced in the group given 1 g/kg yeast glucomannan, compared to the aflatoxin group. These results show that yeast glucomannan effectively diminished the adverse effects of aflatoxin on the pathological changes and that the higher concentration of yeast glucomannan (1 g/kg) was more effective than the lower concentration (0.5 g/kg) and itself had no adverse effect.


Subject(s)
Aflatoxins/antagonists & inhibitors , Mannans/therapeutic use , Mycotoxicosis/veterinary , Poultry Diseases/drug therapy , Aflatoxins/toxicity , Animals , Bursa of Fabricius/pathology , Chickens , Kidney/pathology , Liver/pathology , Male , Mycotoxicosis/drug therapy , Mycotoxicosis/pathology , Poultry Diseases/pathology , Spleen/pathology , Thymus Gland/pathology
15.
Vet Res Commun ; 28(8): 727-46, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15609872

ABSTRACT

The combined toxic effect of ochratoxin A (OTA) and penicillic acid (PA) on the body mass, the weight and pathomorphology of some internal organs was studied in 85 broiler chickens fed a mouldy diet containing 130, 300 or 800 ppb OTA and 1000-2000 ppb PA. The main pathomorphological changes were cloudy swelling and granular degeneration in the epithelium and mononuclear cell proliferation and activation of capillary endothelium in the kidney and liver; degenerative changes and depletion of lymphoid cells in lymphoid organs (bursa of Fabricius, thymus and spleen) were also seen. Protective effects of 5% total water extract of artichoke and a new natural phytosubstance Rosallsat against these pathomorphological changes were observed. A significant decrease in body mass and relative weight of lymphoid organs was found after 6 weeks of exposure and a greater decrease after 10 weeks of exposure to OTA and PA, and a protective effect of artichoke extract and a slight effect of Rosallsat against that decrease was observed. A significant increase in relative weight of liver and kidneys was also observed as well as a protective effect of artichoke extract against that increase. The quantity of OTA and the percentage of positive samples were significantly lower in tissues of chickens treated with artichoke extract or Rosallsat in addition to OTA than in those treated with only OTA.


Subject(s)
Chickens , Cynara scolymus/chemistry , Mycotoxicosis/veterinary , Ochratoxins/toxicity , Penicillic Acid/toxicity , Plant Extracts/therapeutic use , Poultry Diseases/drug therapy , Animals , Body Weight/drug effects , Bursa of Fabricius/pathology , Dose-Response Relationship, Drug , Kidney/pathology , Liver/pathology , Lymphatic System/pathology , Mycotoxicosis/drug therapy , Mycotoxicosis/pathology , Organ Size/drug effects , Poultry Diseases/chemically induced , Poultry Diseases/pathology , Random Allocation , Treatment Outcome
16.
Arch Environ Health ; 58(8): 528-32, 2003 Aug.
Article in English | MEDLINE | ID: mdl-15259433

ABSTRACT

Mycotoxins--toxic substances produced by fungi or molds--are ubiquitous in the environment and are capable of damaging multiple biochemical mechanisms, resulting in a variety of human symptoms referred to collectively as "mycotoxicosis." In fact, mycotoxins mimic multiple xenobiotics, not only with respect to their ultimate damage, but also in their routes of detoxification. This suggests potential therapeutic options for the challenging treatment of mycotoxicosis. In this brief review, the author examines the use of lipoic acid as an example of an inexpensive and available nutrient that has been shown to protect against, or reverse, the adverse health effects of mycotoxins.


Subject(s)
Antioxidants/therapeutic use , Mycotoxicosis , Mycotoxins/adverse effects , Sick Building Syndrome , Thioctic Acid/therapeutic use , Air Pollution, Indoor/adverse effects , Air Pollution, Indoor/prevention & control , Animals , Antioxidants/pharmacology , Biomedical Research , Disease Models, Animal , Drug Evaluation, Preclinical , Humans , Inhalation Exposure/adverse effects , Inhalation Exposure/prevention & control , Mycotoxicosis/drug therapy , Mycotoxicosis/etiology , Mycotoxicosis/prevention & control , Sick Building Syndrome/drug therapy , Sick Building Syndrome/etiology , Sick Building Syndrome/prevention & control , Thioctic Acid/pharmacology , Xenobiotics/adverse effects
17.
Res Vet Sci ; 71(1): 59-66, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11666149

ABSTRACT

The amelioration of aflatoxicosis in broiler chickens was examined by feeding two concentrations of natural zeolite (clinoptilolite). Clinoptilolite (ClI), incorporated into the diet at 1.5 and 2.5 per cent, was evaluated for the ability to reduce the deleterious effects of 2.5 mg total aflatoxin (AF) kg(-1)diet on growing broiler chicks from 1 to 21 days of age. A total of 360 broiler chicks were divided into six treatment groups [Control, AF, CLI (1.5 per cent), AF plus CLI (1.5 per cent), CLI (2.5 per cent), and AF plus CLI (2.5 per cent)] each consisting of 60 chicks. Compared to controls, the AF consuming chicks showed increases in the relative weights of liver and kidney; and gross-histopathologic hepatic lesions such as paleness, friability, diffuse hydropic degeneration and/or fatty change, bile-duct hyperplasia and periportal fibrosis. Glumerular hypertrophy, increases in the number of mesengial cells and hydropic degeneration of tubuler epithelium in kidneys of chicks fed diet AF alone were also observed. Atrophy and lymphoid depletion were seen in the thymuses and bursa of Fabricius from the chicks fed AF alone. The additions of CLI (1.5 and 2.5 per cent) to the AF -containing diet moderately (significantly in some cases) decreased the number of affected broilers and/or the severity of lesions. The addition of CLI to the AF-free diet did not produce any significant changes compared with the controls. These results suggest that CLI was effective for the protection of AF-toxication in broilers and it could contribute to a solution of the AF problem in poultry production.


Subject(s)
Aflatoxins/toxicity , Chickens , Mycotoxicosis/veterinary , Poultry Diseases/drug therapy , Zeolites/pharmacology , Animals , Bursa of Fabricius/pathology , Female , Histocytochemistry/veterinary , Kidney/pathology , Liver/pathology , Male , Mycotoxicosis/drug therapy , Mycotoxicosis/pathology , Organ Size/drug effects , Poultry Diseases/pathology , Thymus Gland/pathology
18.
Br Poult Sci ; 41(5): 640-50, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11201446

ABSTRACT

1. A study was conducted to evaluate the individual and combined effects of aflatoxin B1 (AF), ochratoxin A (OA) and T-2 toxin (T-2) on performance, organ morphology serum biochemistry and haematology of broiler chickens and the efficacy of esterified-glucomannan (E-GM), a cell wall derivative of Saccharomyces cerevisiae1026 in their counteraction. 2. Two dietary inclusion rates of AF (0 and 0.3 mg/kg), OA (0 and 2 mg/kg), T-2 (0 and 3 mg/kg) and E-GM (0 and 1 g/kg) were tested in a 2 x 2 x 2 x 2 factorial manner on a total of 960 broiler chickens from 1 to 35 d of age in an open sided deep litter pen house. 3. Body weight and food intake were depressed by all the mycotoxins, OA being the most toxic during early life. 4. Weights of kidney and adrenals were increased by AF and OA. Liver weight was increased by AF (17.8%), while OA increased gizzard weight (14.6%) and reduced bone ash content (8.1%). T-2 toxin showed no effect on these variables. 5. Serum cholesterol content was decreased and activity of serum gamma glutamyl transferase (GGT) was increased by AF and OA while serum protein content was decreased by AF. These effects were more pronounced at 21 d than at 35 d of age. Inconsistent responses were seen in the other variables: blood urea nitrogen (BUN) content, activities of serum alanine amino transferase and aspertate amino transferase. Blood haemoglobin content was depressed by AF and T-2, whereas blood coagulation time was prolonged by OA. 6. Significant interactions were observed between any 2 toxins for their additive effects on body weight, food intake, bone ash content and serum GGT activity at 21 d. Conversely, antagonistic interactions were observed among any 2 of the toxins for their effects on variables such as serum protein and serum cholesterol content. Simultaneous feeding of all 3 mycotoxins did not show increased toxicity above that seen with any 2. 7. Esterified-glucomannan increased body weight (2.26%) and food intake (1.6%), decreased weights of liver (32.5%) and adrenals (18.9%) and activity of serum GGT (8.7%), and increased serum protein (14.7%), cholesterol (21.9%), BUN (20.8%) and blood haemoglobin (3.1%) content, indicating its possible beneficial effect on mycotoxicosis in broiler chickens.


Subject(s)
Chickens/growth & development , Mannans/pharmacology , Mycotoxicosis/drug therapy , Mycotoxicosis/veterinary , Mycotoxins/toxicity , Poultry Diseases/drug therapy , Adrenal Glands/chemistry , Adrenal Glands/physiology , Aflatoxin B1/toxicity , Alanine Transaminase/blood , Animals , Aspartate Aminotransferases/blood , Blood Proteins/analysis , Blood Urea Nitrogen , Body Weight , Cholesterol/blood , Female , Gizzard, Avian/chemistry , Gizzard, Avian/physiology , Hemoglobins/analysis , Kidney/chemistry , Kidney/physiology , Liver/chemistry , Liver/physiology , Male , Mycotoxicosis/physiopathology , Ochratoxins/toxicity , Organ Size/physiology , Poultry Diseases/pathology , Poultry Diseases/physiopathology , Random Allocation , T-2 Toxin/toxicity , Tibia/chemistry , Whole Blood Coagulation Time , gamma-Glutamyltransferase/blood
19.
Toxicol Lett ; 89(2): 115-22, 1996 Dec 16.
Article in English | MEDLINE | ID: mdl-8960153

ABSTRACT

In one experiment, the effect of inorganic sorbents on the metabolic fate of aflatoxin B1 (AFB1) was studied in turkey poults. At 5 weeks of age, female poults were surgically colostomized and 9 days later orally dosed with 0.75 mg AFB1/kg BW. Hydrated sodium calcium aluminosilicate (HSCAS), acidic HSCAS, and activated charcoal (AC) were tested, by concomitant administration with AFB1. Urine was collected up to 48 h post-dosing and analyzed for aflatoxin M1 (AFM1) which was the major metabolite found in all treatment groups. Hydrated sodium calcium aluminosilicate, previously proven beneficial in alleviating aflatoxicosis in farm animals, reduced urinary AFM1 output when orally dosed simultaneous with AFB1. Also, acidic HSCAS and AC significantly decreased AFM1 excretion when administered concomitantly with AFB1. A second experiment was conducted to evaluate the ability of two types of AC to modify aflatoxicosis when added to aflatoxin (AF)-contaminated (from culture material) diets of turkey poults. Although AC was able to decrease AFM1 excretion in the first experiment, no protective effects from AF toxicity were observed in the feeding study.


Subject(s)
Aflatoxin M1/metabolism , Aluminum Silicates/pharmacology , Charcoal/pharmacology , Mycotoxicosis/drug therapy , Aflatoxin M1/urine , Animal Feed/microbiology , Animals , Blood Chemical Analysis , Body Weight/drug effects , Female , Mycotoxicosis/prevention & control , Organ Size/drug effects , Turkeys
20.
Poult Sci ; 74(4): 626-32, 1995 Apr.
Article in English | MEDLINE | ID: mdl-7792233

ABSTRACT

Male broiler chicks were fed diets containing 0 or 3.5 mg aflatoxin (AF)/kg from 1 to 28 d of age. The diets were amended with either .5% hydrated sodium calcium aluminosilicate (HSCAS), 16.5 mg virginiamycin (VM)/kg of diet, or .5% HSCAS + 16.5 mg VM/kg of diet to determine the effects of these compounds during aflatoxicosis. When compared with controls (814 g), BW gains were significantly lower for broilers fed the AF (731 g) or AF+VM (716 g) diets. No differences were found between the BW gains of chicks fed diets without aflatoxin (814 g) and those of chicks fed AF+HSCAS (793 g) or AF+HSCAS+VM (803 g), indicating approximately 75% protection against decreased BW gain by HSCAS and 87% protection by the HSCAS+VM combination. Relative weights of the liver and kidney and creatine kinase activity were significantly increased and albumin, total protein, cholesterol, uric acid, and inorganic phosphorus concentrations were decreased in chicks fed the diet containing AF alone. With the exception of albumin, HSCAS was effective in restoring these values to control values. The findings of this research suggest that HSCAS and HSCAS+VM can counteract some of the toxic effects of AF in growing broiler chicks.


Subject(s)
Aluminum Silicates/administration & dosage , Chickens , Mycotoxicosis/veterinary , Poultry Diseases/drug therapy , Virginiamycin/administration & dosage , Animals , Body Weight/drug effects , Drug Therapy, Combination , Male , Mycotoxicosis/blood , Mycotoxicosis/drug therapy , Organ Size/drug effects , Poultry Diseases/blood , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...